David Matthews
Emeritus Professor of Diabetes Medicine
- Emeritus Founding Chairman, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM)
- Dean of Degrees and Emeritus Fellow of Harris Manchester College, Oxford
Recent publications
-
Sodium-glucose co-transporter-2 inhibitors: A paradigm shift in treatment for type 2 diabetes.
Matthews DR., (2024), Diabetes, obesity & metabolism, 26 Suppl 5, 3 - 4
-
Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis.
Avgerinos I. et al, (2023), Diabetes Obes Metab
-
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.
Karagiannis T. et al, (2022), Diabetologia
-
Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis.
Avgerinos I. et al, (2021), Diabetes Obes Metab
-
Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control.
Tremblay J. et al, (2021), Diabetologia